Compare, Analyse AANJANEYA LIFECARE with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 DR. DATSONS LABS   ACTAVIS
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
ACTAVIS
Dec-18
DR. DATSONS LABS/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs12614,418-   
Low Rs319,671-   
Sales per share (Unadj.) Rs133.03,536.6-  
Earnings per share (Unadj.) Rs0.2-1,139.2-  
Cash flow per share (Unadj.) Rs6.6372.7-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs128.814,587.0-  
Shares outstanding (eoy) m31.66332.60-   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.63.4 17.3%   
Avg P/E ratio x516.1-10.6 -4,881.4%  
P/CF ratio (eoy) x11.832.3 36.6%  
Price / Book Value ratio x0.60.8 73.6%  
Dividend payout %00-   
Avg Mkt Cap Rs m2,4774,006,015 0.1%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m560-   
Avg. sales/employee Rs ThNM69,602.9-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM-22,419.1-  
INCOME DATA
Net Sales Rs m4,2111,176,289 0.4%  
Other income Rs m7922,495 0.3%   
Total revenues Rs m4,2891,198,784 0.4%   
Gross profit Rs m56930,825 1.8%  
Depreciation Rs m204502,838 0.0%   
Interest Rs m43067,879 0.6%   
Profit before tax Rs m13-517,397 -0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m0131,957 0.0%   
Tax Rs m6-6,557 -0.1%   
Profit after tax Rs m5-378,883 -0.0%  
Gross profit margin %13.52.6 515.3%  
Effective tax rate %48.01.3 3,790.1%   
Net profit margin %0.1-32.2 -0.4%  
BALANCE SHEET DATA
Current assets Rs m6,852482,452 1.4%   
Current liabilities Rs m6,711426,793 1.6%   
Net working cap to sales %3.34.7 70.8%  
Current ratio x1.01.1 90.3%  
Inventory Days Days16120 821.3%  
Debtors Days Days31866 480.3%  
Net fixed assets Rs m3,673133,149 2.8%   
Share capital Rs m3170-   
"Free" reserves Rs m3,7610-   
Net worth Rs m4,0784,851,644 0.1%   
Long term debt Rs m1,6711,708,440 0.1%   
Total assets Rs m12,6337,584,224 0.2%  
Interest coverage x1.0-6.6 -15.5%   
Debt to equity ratio x0.40.4 116.4%  
Sales to assets ratio x0.30.2 214.9%   
Return on assets %3.4-4.1 -84.0%  
Return on equity %0.1-7.8 -1.5%  
Return on capital %7.7-4.8 -158.5%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Net fx Rs m3570-   
CASH FLOW
From Operations Rs m1,345420,244 0.3%  
From Investments Rs m-2,256230,869 -1.0%  
From Financial Activity Rs m-1,200-721,264 0.2%  
Net Cashflow Rs m-2,111-69,801 3.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 74.51 Rs / USD

Compare DR. DATSONS LABS With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare DR. DATSONS LABS With: BIOCON   VENUS REMEDIES  DR. REDDYS LAB  ALKEM LABORATORIES  DIVIS LABORATORIES  



Today's Market

Sensex Opens 440 Points Higher; Nestle India and ACC Among Top Stocks in Focus(09:30 am)

Asian stock markets are trading on a mixed note today as investors await the release of China's latest benchmark lending rate.

Related Views On News

Nazara Technologies IPO: Should You Apply? (IPO)

Mar 17, 2021

Should you bet on this gaming company backed by ace investor Rakesh Jhunjhunwala?

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games? (The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

A Stock with 700% Return Potential Comes with Additional Payoffs (Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

11x Bankruptcy to Bluechip Stock: A Rare India Revival Story (Profit Hunter)

Apr 16, 2021

There is no stopping this 11-bagger stock from significant upside.

Why Did the Market Crash on Monday? (Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

A Warning About Bubbles (Fast Profits Daily)

Apr 16, 2021

Those who don't learn from financial history are doomed to lose their money.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 8-QTR ANALYSIS

COMPARE DR. DATSONS LABS WITH

FEATURED VIDEOS

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

The Dilemma of Investing in Bharti Airtel

More Featured Videos

MARKET STATS